Epoprostenol

Back to search

Molecule Structure

Scientific Name

Epoprostenol

Description of the Drug

Epoprostenol is a vasodilator and platelet aggregation inhibitor used for the management of primary pulmonary hypertension and pulmonary hypertension in patients with heart failure.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01240

Brand Name(s)

Not Available

Company Owner(s)

Actelion Pharmaceuticals Us Inc, Glaxosmithkline Llc, Teva Pharmaceuticals Usa, Sun Pharmaceutical Industries Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Prostanoid IP receptor SINGLE PROTEIN AGONIST CHEMBL1995

Unichem Links

SureChEMBL SCHEMBL8041
Human Metabolome Database HMDB0001335
DrugBank DB01240
PubChem: Thomson Pharma 14900947
PubChem 5282411
Nikkaji J17.550A
EPA CompTox Dashboard DTXSID5022988
LipidMaps LMFA03010087
DrugCentral 1034
Metabolights MTBLC15552
Brenda 47566 204317 29197 6018 3844 44649
Guide to Pharmacology 1915
GSRS 6ed7532f-7e36-4ff6-902d-c57e042d5a76
rxnorm FLOLAN EPOPROSTENOL EPOPROSTENOL SODIUM
ChEBI 15552
ZINC ZINC000003813078